Global X Copper Miners ETF vs Nuwellis Inc — how do they compare? Global X Copper Miners ETF trades at $85.75 (market cap $7.10B), while Nuwellis Inc trades at $0.69 (market cap $2.20M). The key difference: Global X Copper Miners ETF is far larger — about 3227.3× Nuwellis Inc's market cap, and Global X Copper Miners ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global X Copper Miners ETF for 51 Days and Nuwellis Inc for 26 Days on average.
| COPX | NUWE | |
|---|---|---|
Market Cap | $7.10B | $2.20M |
Volume | 2,871,128 | 121,544 |
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $96.45 | $146.65 |
52-Week Low | $57.43 | $0.68 |
Typical Hold Time | 51 Days | 26 Days |
Enterprise Value | — | -$1.52M |
Signals from Pluang's Aura AI — not financial advice
COPX (Global X Copper Miners ETF) trades at $85.75, up 2.6% with a bearish technical outlook from moving averages. The ETF faces mixed sentiment as copper demand surges due to AI and electrification trends, while miner stocks lag behind metal prices. Recent articles highlight copper's strategic importance but note global surplus concerns and Federal Reserve policy impacts on mining equities.
Outlook hinges on copper price sustainability amid AI-driven demand, though miner valuations remain pressured. Key risks include global copper surplus projections and Fed policy volatility. Opportunities exist from structural copper deficits and operational leverage if metal prices hold near record highs above $6.85/lb (GuruFocus, September 8, 2026).
NUWE trades at $0.689, down 0.25% with a bearish technical signal despite oversold RSI readings. The company shows promising revenue growth (14% YoY in Q2 2026) and strong gross margins (69.69%), but faces significant profitability challenges with a -125.63% net income margin and negative cash flow. Recent news highlights console adoption growth and strategic expansions in pediatric care.
While NUWE's valuation metrics appear attractive (P/E 0.03, P/S 0.01), the company's persistent losses and negative cash flow present substantial risk. Analyst sentiment is mixed with a 50/50 buy/hold split. The stock offers speculative potential if management can achieve profitability, but requires careful risk assessment given current financial challenges.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
COPX tracks the Solactive Global Copper Miners Total Return Index, providing broad exposure to companies worldwide involved in copper mining, refining, and exploration. It serves as an equity-based alternative to copper futures, offering a leveraged play on copper demand driven by global infrastructure and the clean energy transition.
Read more on COPX →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →